Nisa Investment Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94K | Sell |
3,269
-91
| -3% | -$2.62K | ﹤0.01% | 1419 |
|
|
2025
Q1 | $113K | Buy |
3,360
+6
| +0.2% | +$201 | ﹤0.01% | 1365 |
|
|
2024
Q4 | $171K | Buy |
3,354
+188
| +6% | +$9.61K | ﹤0.01% | 1334 |
|
|
2024
Q3 | $162K | Sell |
3,166
-163
| -5% | -$8.33K | ﹤0.01% | 1327 |
|
|
2024
Q2 | $149K | Buy |
3,329
+59
| +2% | +$2.64K | ﹤0.01% | 1382 |
|
|
2024
Q1 | $153K | Buy |
3,270
+58
| +2% | +$2.72K | ﹤0.01% | 1370 |
|
|
2023
Q4 | $114K | Sell |
3,212
-200
| -6% | -$7.12K | ﹤0.01% | 1406 |
|
|
2023
Q3 | $101K | Buy |
3,412
+12
| +0.4% | +$357 | ﹤0.01% | 1501 |
|
|
2023
Q2 | $61.3K | Buy |
3,400
+2,379
| +233% | +$42.9K | ﹤0.01% | 1680 |
|
|
2023
Q1 | $16K | Buy |
1,021
+970
| +1,902% | +$15.2K | ﹤0.01% | 2065 |
|
|
2022
Q4 | $1K | Hold |
51
| – | – | ﹤0.01% | 2413 |
|
|
2022
Q3 | $1K | Buy |
+51
| New | +$1K | ﹤0.01% | 2405 |
|
|
2022
Q2 | – | Sell |
-1,630
| Closed | -$36K | – | 2393 |
|
|
2022
Q1 | $36K | Hold |
1,630
| – | – | ﹤0.01% | 1923 |
|
|
2021
Q4 | $31K | Buy |
+1,630
| New | +$31K | ﹤0.01% | 1840 |
|